Emulsion of Propofol-Induced Hyperlipidemia in 1 Case of Pharmaceutical Care

OBJECTIVE To pay pharmaceutical care on hyperlipidemia caused by continued use of sedative propofol for patients who suffer from mechanical ventilation. METHODS To the case which the patients with necrotizing fasciitis, who are treated with propofol emulsion, and lead to hyperlipidemia, clinical pharmacist timely put their intervention advice forward during pharmaceutical care. And they should also analyze and summarize the data to guarantee the smooth progress of the treatment. RESULTS Pharmacist＇s recommendations has been adopted. It＇s proved to be a kind of successful pharmaceutical care in this case. Also, it contributes to improve drug safety, medical quality assurance. CONCLUSION In the process of clinical drug treatment, clinical pharmacist should play their special skills to not only assure the safety and effection of drug treatment, but also reduce the incidence of adverse drug events.